Showing results (251-260 of 364) with videos related to
Sort By:
Pageof 37
Lung Cancer (Amsterdam, Netherlands)|June 26, 2012
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PETMatthias Scheffler, Carsten Kobe, Thomas Zander, et al.Lung Cancer (Amsterdam, Netherlands)|May 3, 2022
Patient perception of burden of disease and treatment preferences in non-small cell lung cancer: Results from a European surveyAmanda Tufman, Kathy Redmond, Andromachi Giannopoulou, et al.Science Advances|February 21, 2019
New tolerance factor to predict the stability of perovskite oxides and halidesChristopher J Bartel, Christopher Sutton, Bryan R Goldsmith, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2015
Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysisGeorg Kuhnert, Ronald Boellaard, Sergej Sterzer, et al.Journal of the American Chemical Society|October 25, 2016
Noncovalent Bonding Controls Selectivity in Heterogeneous Catalysis: Coupling Reactions on GoldStavros Karakalos, Yunfei Xu, Fairoja Cheenicode Kabeer, et al.ACS Catalysis|February 28, 2022
Learning Design Rules for Selective Oxidation Catalysts from High-Throughput Experimentation and Artificial IntelligenceLucas Foppa, Christopher Sutton, Luca M Ghiringhelli, et al.The Journal of Chemical Physics|July 11, 2024
Efficient all-electron hybrid density functionals for atomistic simulations beyond 10 000 atomsSebastian Kokott, Florian Merz, Yi Yao, et al.The Journal of Chemical Physics|August 3, 2017
Properties of the water to boron nitride interaction: From zero to two dimensions with benchmark accuracyYasmine S Al-Hamdani, Mariana Rossi, Dario Alfè, et al.The Oncologist|September 11, 2015
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR InhibitorsDavid F Heigener, Christian Schumann, Martin Sebastian, et al.Plos One|October 14, 2009
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controlsAndreas Keller, Petra Leidinger, Julia Lange, et al.Pageof 37